| 000 | 01860 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515003159.0 | ||
| 264 | 0 | _c20060131 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jc.2005-1632 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJawa, A | |
| 245 | 0 | 0 |
_aImpaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cJan 2006 |
||
| 300 |
_a31-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuminuria _xphysiopathology |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBrachial Artery _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNitroglycerin |
| 650 | 0 | 4 |
_aProteinuria _xphysiopathology |
| 650 | 0 | 4 | _aUltrasonics |
| 650 | 0 | 4 | _aUltrasonography |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 650 | 0 | 4 | _aVasodilator Agents |
| 650 | 0 | 4 | _aWhite People |
| 700 | 1 | _aNachimuthu, S | |
| 700 | 1 | _aPendergrass, M | |
| 700 | 1 | _aAsnani, S | |
| 700 | 1 | _aFonseca, V | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 91 _gno. 1 _gp. 31-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2005-1632 _zAvailable from publisher's website |
| 999 |
_c15848497 _d15848497 |
||